{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Discriminative Stimulus Properties of S(−)-Nicotine: “A Drug for All Seasons",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "anatabine/rosecrans2017.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, immediately after exposure to nicotine, there is a “stimulant-kick” caused, in part, by its stimulation of the adrenal glands and resultant discharge of epinephrine (adrenaline)",
      "key": "553875e16e1b684dce0c0f5e976142b94ee0f58062a9480a2961d253b9128fee0c8c31661820db6e287f6adbe96386efbf72bb79c185db79588c4a6427382b16",
      "line": 79,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, immediately after exposure to nicotine, there is a “stimulant-kick” caused, in part, by its stimulation of the adrenal glands and resultant discharge of epinephrine (adrenaline)",
      "key": "8452d2d53871b8753c178c67044c89454ff3ef8f8a53f94fd074b64bbacfd08819a005698f257402607328b105ffe1ec2985d0748204bd0ae84f8bdcff5b870b",
      "line": 80,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 14,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Pancreas": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Nicotine also suppresses insulin output from the pancreas, which indicates that smokers are usually hyperglycemic (higher blood sugar level)",
      "key": "3074341e99ac5e3fb13a976d63a7b4262922304e03c8a762b8faf53bfc3d95bb20200ce88c265bcb04c104ae093b9c4410be6b3a6d918c586f880e9e89a15fde",
      "line": 96,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 14,
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "ee056b1e615152237ee60d572c735576620a5637662480eb78e6138b2ff14bca2c2eead4c32d0bf97fd5e96bdb93475a2b90756d665c6a6eb49fba25fb17b595",
      "line": 105,
      "relation": "association",
      "source": 14,
      "target": 43
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "63f69a72f1b0c83aa8a90a1fe0c333a05d9b1d1a39d2b05a3147a1011761893516b7fd36358db7ee176bf977c6b5130349711b4ba98cd5778a3c8285a09a30d1",
      "line": 106,
      "relation": "increases",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine activates all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12])",
      "key": "6157c29c747e2fdc633b5e24f6560ad0bc50aa2efbd2ff3d3655ea5bd12fd91936166f4380c661b8649e4391222215acc5f6dee357d3a91a2c57b0f10a2d898f",
      "line": 191,
      "relation": "increases",
      "source": 14,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "1e91b0b19df7bbc6c13a8ef8da08722024f09c6740b90795310c178342df357c46c49d5f5499d4341a8eb06acce95e4247d66bddc8ec812be3d7bac32ed0b0ce",
      "line": 115,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 14,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Nucleus Accumbens": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, (-)-nicotine may increase dopamine activity at some brain sites such as the nucleus accumbens, an area thought to be important to drugs of abuse (e.g., [14, 101, 102]; but see [16, 103])",
      "key": "27136415fba68a75353a46fa55f903812bf75d8bfb9c9ba5585832cda5b5105b08859aed38ced35f7d4eaa519ca87bff562337958d37d7122742b3915bbd9e5b",
      "line": 200,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, in rodents, administration of low doses of nicotine produced increased motor activity whereas high doses produced decreased motor activity (e.g.,[17, 18])",
      "key": "a4fb8b62dc6ea00624b65f039003b489c8e072f07a39e4bb4270a193ecb0345e6d59ce7e4409aee57a86a1c8de3f3407610eb2d15208f4c9508a1da6daeb3441",
      "line": 127,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": ". It is now well established that nicotine binds to nicotinic acetylcholine receptors (nAChRs) at the cellular level and is the prototype drug used to classify nAChRs",
      "key": "cc0ef4def2f8c5b9f52a7af3e943b539815930e7f9b65a4a19595a690091b24842715648350dba7aea4138ea3e9c497f17baa47a73a7e384e801f6af81871971",
      "line": 183,
      "relation": "increases",
      "source": 14,
      "target": 39
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine activates all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12])",
      "key": "a35ad88fcb112b62798ee77b39196faf49f95a45a3cad5b3710e59b9844c18a24b20e0b426bc7798ee90324b21188ec74875a99703aee78912571b9f7625eae0",
      "line": 190,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 14,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In antagonism tests, (-)-nicotine failed to block the stimulus effects of mecamylamine",
      "key": "9130311e80bfc28ee943dc0613c22e6749bcb9e93b2f1f4104e0664ba895b49808e0435686bc0c2a825361f037c4fa4e3688d4e7e2a693d90f2396366a591ab3",
      "line": 312,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 14,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "738494636440aad65d2e8e7876380fe76a546402c88d8ba2ae8a1b8be6a7bc3da44fd5377b0355c88ddeeb8a5b8730cfc53caf4dc36d10acd50b1ca0059fe866",
      "line": 323,
      "relation": "negativeCorrelation",
      "source": 14,
      "subject": {
        "modifier": "Activity"
      },
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "6e0d26d70610a54d22a8145e5a4e7d08fba4ffe7dced9f5e736103528a63547b3138791b54a412979ee5697f8170dfd2f45d6df2d2d0105e75efc086a51a63a5",
      "line": 86,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 9,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "ece0df4631c71de9989b8cb04d8466fd2f40c3d5b5487cb0f9bfa549f5f718473ab3257604f1bed319bec90aee28fbfe4f0ff7e77c6070920875c81c52ad4f94",
      "line": 87,
      "relation": "increases",
      "source": 9,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "e1be72d7e5980cc73b70a8b29ab65f5e1fafe286b9473beee225fac55a99395f729075671bf00b3dd699fd61d00eb18c16c388a633fea105160b92ee8c215bf0",
      "line": 88,
      "relation": "increases",
      "source": 9,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 34
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Adrenal Glands": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The release of epinephrine stimulates the body and causes a sudden release of glucose as well as an increase in blood pressure, respiration, and heart rate",
      "key": "4ca8bfc5822d0c34958ff60c63b31b0da1881fc7983bc85b2ab82880e6bcb7619d001c4c0a5a12048d6306851285140b08dfe9a17eb31c1665b5204c6b988761",
      "line": 89,
      "relation": "increases",
      "source": 9,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Nicotine also suppresses insulin output from the pancreas, which indicates that smokers are usually hyperglycemic (higher blood sugar level)",
      "key": "c7828e60e6f6597381e2f9191169fdfc62f6be469f6d410c85783761cf1d42e67ce55416e755a3fc0d586d5245cb920f31db91f8bf6aad503c15930529bdc3bc",
      "line": 98,
      "relation": "increases",
      "source": 67,
      "target": 19
    },
    {
      "key": "f21593cf37a3589a13450fec58fa0f164697c05a5810af35608eb2c510c7fc7601448127eb5a7896d7006cb32b7fe2b0bb6ac9a343d0677b83d9dd0e28b87111",
      "relation": "hasComponent",
      "source": 43,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Centrally, (-)-nicotine has affinity for all brain nAChR subtypes, but binds preferentially and with high affinity to α4β2 nAChRs (e.g., [12, 13])",
      "key": "861dba7933d456a6bcb5b1685373a8b4d285269ea6a4718bafff4ed73fb8554f994c3c8f239c3f3a7a56ccbfe8f97c77a71b7638875e7b805cc5b6192e2d10d6",
      "line": 105,
      "relation": "association",
      "source": 43,
      "target": 14
    },
    {
      "key": "6fc95cd6e2424c678aaf402f97a2725a28e9fd7dd250dd94572f9cb3d9514f7517ef41969b927176d722c69d056e5c52dd0b0a9c3d0b627539317865b4857250",
      "relation": "hasComponent",
      "source": 40,
      "target": 14
    },
    {
      "key": "b1a525a6a6a3c63de0151b9d79fc22b940f6d24ac465099e31c407a48f77e95da4b5105a02f7cf2727bca5e0f5dc2a78c639afdf91ea8af68a6aa837b8312349",
      "relation": "hasComponent",
      "source": 40,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "66a8146dbd38eb62860d2ca4aa92afe806c68e6d56f25a2c6fbab34a10c32963c78473be480fb3266d72a13e789cd0edd20b1993df7e80fc309f5280e93b89ad",
      "line": 116,
      "relation": "regulates",
      "source": 11,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Moreover, (-)-nicotine (indirectly) can produce a release of dopamine in brain regions that are thought to control pleasure and motivation; dopamine is thought to underlie the pleasurable sensations experienced by smokers (e.g., [14, 15] but see [16]).",
      "key": "bb3d995caa16b355f38832c99daa07ec73ca32cad192c09efb122136d99e454b99c92b1bc7a93e959ac4b600a548ab3a31690e24db9a0c26f8f89821209c7b36",
      "line": 117,
      "relation": "regulates",
      "source": 11,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9989": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, in rodents, administration of low doses of nicotine produced increased motor activity whereas high doses produced decreased motor activity (e.g.,[17, 18])",
      "key": "3464ac7b930668c7c476087f608dbe902eca87fa995680bcd23845c681fe234e0a0720fe8bd1589567a0be5d114cf8aeebab03dd68732ea6725d134f4a67cdbb",
      "line": 127,
      "relation": "negativeCorrelation",
      "source": 51,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "2340ca57fd9f346850fd66d6a92866c13bf8f7c665ebd309a57cb1f95ced528d0311014fe8b6440a00a28c375b13a520ccb07fc3e7208a1533fe4c02cd5279ca",
      "line": 136,
      "relation": "increases",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "bbbdfc099a57a2d6aef8fd80265a3c327ff63f5b60b12c4b2baa6123df87c211b618d9d714da7d7e7bec9a347f40b123aaf5cb0ca77bd1f912c2b4dce4546746",
      "line": 138,
      "relation": "increases",
      "source": 4,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "144bcf524baa40c68651d355b250d7112ec0969f24fe78758bda36dbb4e8c949231a2432271b267cd8f5428b8a74b2330bedfcf5490996da0c8c9427fcf9a1e8",
      "line": 137,
      "relation": "increases",
      "source": 2,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In comparison, S(-)-nicotine was shown to be 7 times more toxic than R(+)-nicotine in rats injected intravenously",
      "key": "adcea2c0c0df0bdf0819704722774b4d05216c0460f34aeed842ccdbd26b93bfe051d8915710105c7d9d22b05b2ecac424f91d2333dcf7a95d2ae2664c6056d7",
      "line": 139,
      "relation": "increases",
      "source": 2,
      "target": 61
    },
    {
      "key": "9b55e180e6153a208a1609291b3e8f8ed63d110cd945932c103c5e1e4927cf88e4291682fcd5e0b95d9a754c29cdf7f71ba63b65b2e2eaf7519a42d1dfe34375",
      "relation": "hasComponent",
      "source": 30,
      "target": 14
    },
    {
      "key": "58afc285b2bc67147d8da9605ed85a7de8192b6c0805e679362a24d87c3a610c081bf21c82a85ed321d3dd39d76607176e7ef1b9afff58c97e5c812f0a8c2c7d",
      "relation": "hasComponent",
      "source": 30,
      "target": 6
    },
    {
      "key": "5e2777c4ebfb7d30fd20c1eeab5ab24377dec68103d9f809d8ad80c0b257783af7f861e5dd8b0a74f73c416cc726954bf85f1bf857064af07c2d32d2fbb083b8",
      "relation": "hasComponent",
      "source": 30,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Lastly, S(-)-nornicotine is a minor metabolite of nicotine and, as mentioned previously, is considered a minor alkaloid of tobacco (Fig. 2)",
      "key": "e51342b1f10c0be24e614e900a93d5a44bf54367d0953d801b8bfde68145ac9b571017a7daad7fb7d802c639f6df43592b988b08ca4879a2ebebdc9c7865c3d7",
      "line": 176,
      "relation": "isA",
      "source": 30,
      "target": 15
    },
    {
      "key": "9dd1350527365fb4de624c877712285b7d0b40725f3f19a04ed97fd96aed5244d4f87415a0b8355b4af171136af1c399aa6ecb9521239090ae4cb6918fdb5651",
      "relation": "hasComponent",
      "source": 30,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In the body, nicotine is extensively metabolized and is susceptible to a significant first-pass effect during which 80–90% of it is metabolized by the liver. Also, the lung is able to metabolize nicotine, but to a much lesser degree [78, 79]. ",
      "key": "420eaf5993a1f1ff6f4a2fa1877a8e8e5b72085842f44c2aa79c5774d3a1000b797ac051ef1c1cc0651a48ad5a532a508f77e1a348e1987cf91a9d5a3dbbe17e",
      "line": 157,
      "relation": "increases",
      "source": 28,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "e759aeb957ab6ef63356b84074d612a8298fe6e1f09aca8dad5a3138577b954e1c80519a4db0a24ab9ead681bc8eaa787d84b321bf29058bd2fd5906cb451645",
      "line": 166,
      "relation": "increases",
      "source": 35,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Lastly, S(-)-nornicotine is a minor metabolite of nicotine and, as mentioned previously, is considered a minor alkaloid of tobacco (Fig. 2)",
      "key": "9040f307c75372dfc6e8af1ce4362be14fd9f96bdad65a01f1a2eb94d4646ab9960f687bb0dee01973631a2ff18ceebce3b2ec7c93dc93106c4ab2324effbbb3",
      "line": 175,
      "relation": "increases",
      "source": 35,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "In the body, nicotine is extensively metabolized and is susceptible to a significant first-pass effect during which 80–90% of it is metabolized by the liver. Also, the lung is able to metabolize nicotine, but to a much lesser degree [78, 79]. ",
      "key": "bba0c5a6c2ed93c73091ade8b380f08b82c05ba41aeda786c5a8e100c49c7254bfa6fe9960e079439735d3f58d1b5d1d8ef169f8243756c6d20d7bffd7765839",
      "line": 158,
      "relation": "increases",
      "source": 29,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "cbac0cf2fa6ec7e4b3a64c2d46f745748b60f79021b7d4ff48c92c2442d43d65a07f3b8c4b4256a3c124ca8ad2a276a5593460b8d00ae06a29758a2d8f1efce8",
      "line": 165,
      "relation": "isA",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "933b9087d4ca014a1447ae4ce81d2ff92d39b20db3d5acb9f780f03a081420218601a8413fb3857226124ea6ced15245716c5fb61398a71bb823a71c6493ccd3",
      "line": 167,
      "relation": "association",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In humans, about 70–80% of nicotine is converted to the primary metabolite (-)-cotinine, a lactam derivative (Fig. 2).",
      "key": "2a8903be20d5fd24e93fd89454654d1aacc58e792de39b70c9f9913d349b5dc7f98464bc894669bdeb0d3a30a2db3b499dd776f3b6682ce869c5ac98141ad368",
      "line": 167,
      "relation": "association",
      "source": 13,
      "target": 0
    },
    {
      "key": "521d543e386e0aead3c0850b8574f0207e90142bb14679847bd196837da2bb5dac27738f0c41d513e90a9641b587eed5701efc2a797d7028d26d43e3070a5817",
      "relation": "hasComponent",
      "source": 39,
      "target": 14
    },
    {
      "key": "445e941e25c4ccda830d8af9ef2bd15ace6036488e67928e74e4b0749abe08768ca3c46ba250efd245d87041daba87cc82e66b638e4831ca413e2c59c7cfc903",
      "relation": "hasComponent",
      "source": 39,
      "target": 17
    },
    {
      "key": "c79abdd38d45f782954aa4b3753c9d9ef45a3bd0b17823ec3086f3cba49c5317f59c4f74467e066d771b7d00a769acb55127df3b8b7edf6ef9daf4b7db64da03",
      "relation": "hasMember",
      "source": 46,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "0220416834255b27a5c1c6b920e0462d05933656692a30ccdd8b19f8624ccafaf76f787e893d0ee644afb95af45ac32514477d71b7d7c9e90703631471c0b2f8",
      "line": 211,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "4e399a284e6970aeed9a7e0b097860fdcf45acf8defa4495c318f402ba38191e674645636acbd1e4a5b0b95dc361ba1222c8d9ca1983e2a0d714744e1457a231",
      "line": 212,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 22
    },
    {
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, some biochemical studies suggest that mecamylamine is a channel blocker that inhibits most neuronal nAChRs (e.g., [131–133]).",
      "key": "5b820df3e198c4c08341dc11665a8633c560281f183a82d4047906475953fae72482dc71b2fe02d624cd3c46594bdd22e0dd895874904f2877a97884eb3a03f7",
      "line": 256,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 22
    },
    {
      "annotations": {
        "Cell": {
          "ganglion interneuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Mecamylamine (Inversine®, Vecamyl®; Fig. 3) was developed over 60 years ago and marketed as a ganglionic blocker for the treatment of hypertension (e.g., [127])",
      "key": "95d76e6daa6ec944e27a25ef7a09be18ce0c0d7c5c7871801c64285f5535bb548f910605156e827cfd2c524b21ded3d9e62fbb35908208070a4f9f4d1222a88a",
      "line": 224,
      "relation": "decreases",
      "source": 8,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "b030fe52fc370a28221b71f17d8966c80eb415c71e3349bd18843b74d85131d7b1697a94a9bc72b6c94a0bd323c7e08227b4f4f292ba8ecbf18ebf7556a18ddd",
      "line": 232,
      "relation": "increases",
      "source": 8,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "b18a5d8d085ed427ee17acdae5c524b9f0c13f5ed5c1dcbf81175260677260c57808ec49c6a7cdde46b7fb58c64ef662f9bc509c53b1df71c8c159bc4e495cdb",
      "line": 233,
      "relation": "increases",
      "source": 8,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "ed6263d93bdfdaacb58ea0141031076001476fe0a2bef1e34c2ea34d88bfd355bd4f7c6d20b7d337fd670cbc5a65b5c0dfcfa12dc8f18520434f4725c177ceb3",
      "line": 234,
      "relation": "increases",
      "source": 8,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "a85bf282ec4cee58a643a57467dd6c7b63987a8c371c00079fb19943382ef6b7fbc66ce9e708a8060489043529edca07b9ee419bd71bdc594be7fb3d3ed94dc6",
      "line": 235,
      "relation": "increases",
      "source": 8,
      "target": 48
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " In addition, mecamylamine can produce CNS effects that include tremor, mental confusion, seizures, mania, and depression but the mechanisms by which these effects are produced are unclear",
      "key": "d7c24bb3356d223227310c03af5d71e1b12db4b7c7601a9a6170794dc456c91057ea390f3eec9abee1af8eb268d97dce6bf772a20785207c1d0541fbc4543f4f",
      "line": 236,
      "relation": "increases",
      "source": 8,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Biochemical and pharmacological studies have characterized mecamylamine as a nonselective, voltage dependent and noncompetitive receptor antagonist of neuronal nAChRs and it is often referred to as a “nicotine receptor antagonist.”",
      "key": "151be0644080274ea13d9439f319b0c5480eea3fda3a1bce775f6782cc5d23f886275e38f7e877cc3e7a4202fe26ebb20a1cc41798a3989b283bde6344839f49",
      "line": 251,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "4bdeb20cc768a5c067dcc251509dc5d6c9ffb57326a402af2604d60c4e87606309e73ecdcbfcf527b45dc759010a056c6228a4277bf29ed171d77241bee80d5c",
      "line": 213,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true,
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Research results summarized in Table 5 indicate that DHβE effectively blocked the stimulus effects of (-)-nicotine in rats or mice (but see exceptions reported by [120, 121]).",
      "key": "4a637b0c8b523c556349081b8a47e9ca17dc6a70fdddb8f6b389f9eedfff9065c035e2b6e08a8bfb3ae7f5250209d81495118fa7c087daaf0ec3b399c3bf1718",
      "line": 289,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "725fd702d84c06bb000f659f0b15d73d0093e48041fd06c0cb434d1a55088dcf5fe4923cbe5985f78c2bc3b17fae4809072db1da649d8ad07758c531fa61899a",
      "line": 214,
      "relation": "increases",
      "source": 21,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "8b9bb7ab60d0f0f49b7a2b840cad0694c3644b9128ba6834f2de15135262655ce2c33930eb79827ef87ffbe8a85def1de5329be20cd7efca559aa389a6e298df",
      "line": 215,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "3841": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "DHβE (Fig. 3) is an alkaloid found in plant seeds of Erythrina and is a competitive nAChR receptor antagonist with a preference for neuronal β2 subtypes",
      "key": "297f5b1d030c6545c3958976e13e862f0409d1df280556d0693a2edc976d4b33e2dcb61584a179e8327ba0d398f42df4bb03bc0d3fb173a03585474a333f026f",
      "line": 264,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 46
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "3841": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "DHβE (Fig. 3) is an alkaloid found in plant seeds of Erythrina and is a competitive nAChR receptor antagonist with a preference for neuronal β2 subtypes",
      "key": "0e2439dff763451270bf6c9c744a9cbf89e85512601185175d2e6abcf3f80a0c7e509c776a89821ba2512d8686a55cdf871fcc13ee8624990731a21a2355daba",
      "line": 265,
      "relation": "increases",
      "source": 21,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "8cf6f3b550b8084196dcd57f0f79671b6a4f789c6637cab3030cc127441a6e0446a46b3286eea0214c06f592a9a42877a85575d76443d546411a50797d3f4f1d",
      "line": 273,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "e0e864c2cb062a6c331eec6308b65321d75814907eea6ae68a09ae312869e88038a2b0663190ea08c830176826876ac578ad859a87f48eeed9063f2e4c9e8536",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 27
    },
    {
      "annotations": {
        "Cell": {
          "oocyte": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "262014": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "1312bf9022b0ee1a847fb9050c68807bc65fa173b794af5bf5d72b07f1069ea305a32d4bacc0cf91f1f67dd3be21dfc29437c6173f483e40a6984f902cbf111a",
      "line": 277,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "oocyte": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "262014": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "For example, DHβE (at nM concentrations) blocks α4β2 and α3β2 nAChRs but is much less potent at α3β4 and α7 nAChRs expressed in Xenopus oocytes (e.g., [134–137]).",
      "key": "188c63aea3fbfb33a16faff9deda7faba85069253b08476a629158bc678509b543669a7743308736f9a17c940a084a0843a084860552775c7e0eae37a1ac05eb",
      "line": 278,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 21,
      "target": 24
    },
    {
      "key": "49a0c70f16965d32e0b3260e859b534844229964801ad77514311cfa5e88178551136917781d24fc9e8a27d91c526f34ff5abbbab83ca539dcd3a86e8acbea40",
      "relation": "hasComponent",
      "source": 41,
      "target": 21
    },
    {
      "key": "e7efb2936013cbb14d056d90cbf581ef710fd5dcc4f1c4f3dda43d9a4741567ca6b2c52515cf5304afa7c39c3dc6ca8ffae5e48a7a6e5d1d9e0b5b11bbcb3d0d",
      "relation": "hasComponent",
      "source": 41,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "dc3fab939a46fb2f4d1029806f7457f8546867cfe13dc11594536261e3fc03a9695f9ca83e44e3b783d504cbbca4a3af5d0779ab5375f56771d85638cc357d81",
      "line": 216,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 32,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true,
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Table 5 presents results of MLA/(-)-nicotine combination studies and shows that MLA failed to alter the stimulus effects of (-)-nicotine in rats or mice (but see partial antagonism reported by Quarta et al. [126])",
      "key": "ac24e7a2590972ea40768d52c7be99c5e83407dce4cfb8b860626c53308c87420160936e5b0672bf795187ce9a8d8ebe84c914fc4c12e4add8dd2c6332b1f95c",
      "line": 306,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 32,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "This conclusion is based on the fact that the stimulus effects of nicotine are convincingly blocked by (a) mecamylamine, a voltage dependent noncompetitive channel blocker at nicotinic receptors (Fig. 3; Table 4) and (b) dihydro-β-erythrodine (DHβE), a nicotinic receptor antagonist that shows high affinity for the nAChR α4β2 subunit (Fig. 3; Table 5) but not by methyllycaconitine (MLA), a α7 nicotinic receptor antagonist (Table 5).",
      "key": "ab9d60b1c3975a793e038a953e506d04bf8912258ad5c1fe5b26c5b163c7dd83c8d2fe5293e3eae84e25c376bcde020e268111b72b7628dae3537f571713f725",
      "line": 217,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Its biochemical pharmacology indicates that it is a relatively potent competitive receptor antagonist that is selective for α7 nAChRs (e.g., [139–141]).",
      "key": "9d2fb9d0634e0386526e507ec3485115b8fba162da1f0d0edd521d48151d8b2096bec72c91bfadc4272cbb2b9b94e3fe22523ef5f917a9b83968183359b8282f",
      "line": 297,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " Also, mecamylamine is sometimes used as an anti-addictive drug to help people stop smoking tobacco products (e.g.,[128, 129])",
      "key": "d47a327eaaad1a86795a256ef21cfd7afabae5d320d3b3b1499e9e398f1a5eb6f688f2936fba3548f8f54ed1a309731b82fc332ae05577f5c13a666e60888fbc",
      "line": 243,
      "relation": "decreases",
      "source": 31,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": " Also, mecamylamine is sometimes used as an anti-addictive drug to help people stop smoking tobacco products (e.g.,[128, 129])",
      "key": "b7817f98b7ad9423b6c4d09a74112bfd2966052277d91b06141855cb387ace0b0ed4fd9341690ccca61301c4e08c738fef05f5dfc5f8cc7660fe167b231b4c92",
      "line": 244,
      "relation": "decreases",
      "source": 31,
      "target": 67
    },
    {
      "key": "3e5bb5d662104232606430c36a645a02e06178e6740ce07ca4f4f9c8df64e95a449fcadb7e419907988746be97a0a30b916aac1db782a204c8c724e4ff9ee21d",
      "relation": "hasComponent",
      "source": 42,
      "target": 21
    },
    {
      "key": "cca399a26445b6176391906dcf87bdc9a46dbf727693e1966e00fb6e4a83a7ee8e2c3a77e255a3eb3792794e9e02fdd41cf4e701da802546047ffa4cfb11ef1e",
      "relation": "hasComponent",
      "source": 42,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "2102086326e2eabcab8f2a1f4068966d313676e9216e9462c9f0d1b08119ea8133c8c71b6c70021e4cbb83d61e0fba9bf6dd78b07de2442948a51df6be79e39a",
      "line": 322,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular region",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "Central Nervous System",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 7,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": ". It should be noted that hexamethonium, at relatively low doses, does not block the stimulus effects of (-)-nicotine but when administered at high doses has occasionally been reported to attenuate nicotine-like responding; probably the result of penetration into the CNS of a small proportion of the administered dose of drug (e.g., [35, 38, 64, 106, 146])",
      "key": "6a09182f086cd2d0b7439549cd436bdf55562617abd028e4e62d9398b2cb233730e764a6c9046c135da318260d0be45756c18155ea882dc53874be1427edccbb",
      "line": 323,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "65ce533fbe65a28b225ea4afc001fe7cb93133ee5f5ca91433e228c458d4f646f819bfcf7a70a1d26bf9c927a3500b99f8195192da24f43455f558a3c40837a4",
      "line": 330,
      "relation": "increases",
      "source": 53,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "9fce704f0acb9fd3a8b27659b16189ea96feccd27e7ffe041d840437e31a2301efd7b5e4fe971ca9ab6a50065dc2dbff14476e09e7a5e3418f3db87976579775",
      "line": 331,
      "relation": "increases",
      "source": 53,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "c016db8c022a7bb4f1360264eaa30f791e517da1ff1aff929987ebc1941bd40d325ecf4f103e2dd702cc30b20cdb08f0d42154cf59e1aa9ae3f70d7b3e8870a2",
      "line": 332,
      "relation": "increases",
      "source": 53,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "4013c74a9e9dd4cd9b2542aa92bc2cb8cd5923eb0cb5316a92ff1d8def7d94ea20c06dc861153f05909b846bf40885c8a027147d4fde950b698400d5f718ce04",
      "line": 333,
      "relation": "increases",
      "source": 53,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "3b034e0ee92b739d6371bd106f1795fc618d7b0796f1ad4fee9f37a3693863cdc98b34f9176d5cf2f8ac0ac6ad6139dd5fe206b58fcbc05c166f75bce657a0ff",
      "line": 334,
      "relation": "increases",
      "source": 53,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "98b814b8cac066d061f03fb04e95abbead4e7419c3d4a81b688a3676ed7d65080a428dc3f703830d2b30e6c3a64487382b96e04c73e89df207980ee72f14de0d",
      "line": 335,
      "relation": "increases",
      "source": 53,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "da57ebe9a1da010007ebcd23f64fb8bab122e35a34a0b8aa2713daadae315a129c3a2f98d4ccae90c54bd827022671b9218bf0fc772a2d301317490d921c58b5",
      "line": 336,
      "relation": "increases",
      "source": 53,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "f43a5262de0da50af50fac9ad5597e22d19ea7ebe8aaad047e41b9d04ac2630e9004872edbbd63144f41522aeb9cba49580234532bfce6bbcebc119208f8d0a6",
      "line": 337,
      "relation": "decreases",
      "source": 53,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "6a05e89257bb7efb57b72a384cb0b0c9ee1a339a5792bea243180f6eeeec824b93e98f6bed63a1ff463539bcdc92d486442464f8e37cf3c7fb01ae6f914ebfad",
      "line": 338,
      "relation": "decreases",
      "source": 53,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "(-)-Nicotine withdrawal symptoms might begin within a few hours after the last nicotine product, and include irritability/anger/stress/anxiety, sleep disturbances, depressed mood, craving, cognitive and attention deficits, and increased appetite.",
      "key": "e225c6562a6205cb72755b364f2e3f219a32b6b5b6a94442fc4f857de004bbce85f7ef0bac98f06d6d3b9617692f807cf769d03f217be4547e754935737b73ca",
      "line": 339,
      "relation": "increases",
      "source": 53,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "956237a83849e5ba1ebc14cd6925b53ed1f80bf998a89c07ce43d7d85c1f31d2be58fd813470933662a17e82522a7585fd4a3be90d8d7684b2d250b702334f40",
      "line": 366,
      "relation": "association",
      "source": 53,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "fac61f0da9a21ba1fea8b7b846c88e63575f09c9e9b0a3788be1928abe777de2832304380e1178946f1099b4a3d583aef516f225f3e31ed8a42dac2557cefc6e",
      "line": 381,
      "relation": "association",
      "source": 53,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Lobeline binds with high affinity to α4β2 nAChRs and displays mixed receptor agonist/antagonist actions (e.g., [150–154]).",
      "key": "cebabf7731a00e94f4e4cb9f17a1444a6e8961ee72fddff5c0c72475c5a4fcb414b9181c287dee0949a9e53983eeed5a85651ef7e096c677b6d0adea9ae5098d",
      "line": 344,
      "relation": "increases",
      "source": 1,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Lobeline has, however, been shown to antagonize partially the stimulus effects of (-)-nicotine and S(+)-methamphetamine ([64, 160]; but see [66]).",
      "key": "78870ba55e42db23be5c3382d3d3faadd1e843bcf0d2ba2d85099e177433e67fc812cd62ed449d7cdf859b4fb766efecd48c400b550089daed9549d473204f4d",
      "line": 350,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Lobeline has, however, been shown to antagonize partially the stimulus effects of (-)-nicotine and S(+)-methamphetamine ([64, 160]; but see [66]).",
      "key": "ed365adfe1abff6290099d3007a4d56e7c21594da452525b386e50f1a2b564c64aea08ce146ce035731124f528dadf73c064de567beb76ee22152fe7ccc2d053",
      "line": 351,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 33
    },
    {
      "key": "ab12bdd59289291de9dc61b8010574289abe1d59bdb3f3bb40bb4d554bcf7fd8c8724aaa933e7cdf9b9957ba906198d0fe24df3e8e17bdb583583a7eb829842c",
      "relation": "hasComponent",
      "source": 38,
      "target": 1
    },
    {
      "key": "1ff2931aed48bd64f532b41ddb490f6c1f90846733b428dfed4a4b670a48c5d3eaf28f90bd8830c64b519338a4c598ef1861b055b945b48fa8034fae9f2b6cd9",
      "relation": "hasComponent",
      "source": 38,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Bupropion [a.k.a. amfebutamone, (RS)-2-(tert-Butylamino)-1-(3-chlorophenyl)propan1-one, 3-Chloro tert-butylcathinone, 3-Chloro-N-tert-butyl-β-ketoamphetamine; Fig. 4] is a phenylaminoketone or cathinone derivative that is a weak central nervous system (CNS) stimulant",
      "key": "24e9424a9d71c5067262fe629025f2f6c3a5eab66e7f589818b95df61a0ad2e0d953ba15438db5c221e5457e65d94a3124579b2e32e26c90f009a3f716388114",
      "line": 358,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 10,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "843f0c01861fdfcccb1d2078e360cbd8dd6be97ef38fe8d6ba8a703f223d904ae138fb000da11aeb60694da9a195c520e7b85deeea5374df070e25d14f57526b",
      "line": 365,
      "relation": "decreases",
      "source": 10,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "It is prescribed as medication for the treatment of depression (Wellbutrin®) and/or as an adjunct in smoking cessation therapy (Zyban®).",
      "key": "12aa45ae59e4ef0205be4861fd6766f37d28fd569a877d11f90796b9bb5305a191686b13a636186778349491649070f3b00447e870fe716bd279a539262d2ff0",
      "line": 366,
      "relation": "association",
      "source": 10,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Other studies have reported that bupropion blocked the acute effects of (-)-nicotine in a number of behavioral assays in mice (e.g., [171, 172])",
      "key": "a02fbff7bba9f3413c8dd76960febec237179a92a27dea7a5941ff6bfb17a6a4b8d34ba5727bd74086833c90e970349a4a40c484d315607b6d8520732843a491",
      "line": 373,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 10,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "57b322def035ac59fc0f135c6e381f0989e59030ff854ae4cc6d7058522b32d950cace0a25f1dcf5c750c1ea3d2df7bf21319ea0d9351bab55165b32ec88d879",
      "line": 381,
      "relation": "association",
      "source": 16,
      "target": 53
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "69f10a0e88addb75d610e110e40775d7f5717527c9e6e1765469a70a1c9666f21f61f1ff017e33cdca84de65f4281d5050ec1e2194788515c4c8ef9311608a7d",
      "line": 382,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 16,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Rosecrans JA",
          "Young R"
        ],
        "date": "2018-01-01",
        "first": "Rosecrans JA",
        "last": "Young R",
        "name": "Current topics in behavioral neurosciences",
        "pages": "51-94",
        "reference": "28391535",
        "title": "Discriminative Stimulus Properties of S(-)-Nicotine: \"A Drug for All Seasons\".",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "Varenicline (Chantix®; Fig. 4) is prescribed as an adjunct medication in smoking cessation therapy and is thought to exert its effects as a partial agonist at α4β2 nAChRs and as a full agonist at α7 nAChRs [211, 212]. ",
      "key": "8bbc767cdc675133f003954b6cf1fd64bfecf160cfd8eb09b3a401e56f9340b2609492e3a71e40d3c1fd3056f4521827d9cf4d423f5a9238c49284462dc12cef",
      "line": 383,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 16,
      "target": 24
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(-)-cotinine\")",
      "function": "Abundance",
      "id": "394090032ca1176f3f7350b00cb521d45b54d4d0a81cc2198fe0b4f9f57d513e6247b0b13e50edbbca738fd27a12ef45f7c8f6435f27e213502b05eff7502ca2",
      "name": "(-)-cotinine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"(-)-lobeline\")",
      "function": "Abundance",
      "id": "62fc046ad070aff5fa50c81216a5aa24788d0d78742f84aeb0c986a551b36d28306234d309a861a0d68331e5b9fff631b9736bcedf4d2579c4c1262aa655e1f3",
      "name": "(-)-lobeline",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"(R)-nicotine\")",
      "function": "Abundance",
      "id": "b22b81ec814e3f7a65773213639e9a9f631792093bef762218d239d8bc171a5f8f6f07693378d88e604512c97f2758d98571c4b4a9f1543c32d1b3807ea6edba",
      "name": "(R)-nicotine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"(S)-anabasine\")",
      "function": "Abundance",
      "id": "5eca85f3c39691ebaab623ed008aca2d12aa2ed1212aa20caff75a9ad4c86d960e7c24a4b8c22c03e1031e6dfbbb92f1f6e16841357e49452c2ce5f1d3654acd",
      "name": "(S)-anabasine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"(S)-nicotine\")",
      "function": "Abundance",
      "id": "b07907142091ea66de8a689b987a09d67bbacc5cfc58e37c5dc9268453225054931c21ed350120668446c58799951bf3d6b41f9321c09fce09b049e2ed3f82bd",
      "name": "(S)-nicotine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"insulin (human)\")",
      "function": "Abundance",
      "id": "8c1b53d2df950a0bf68edf17cd7b162c61595801cf59cb3176c54f5ff7bcb698af036ff98e0ff6ae55850a80e7b1dcf79b0cb4c5cce7b57ec9f2842d2632b545",
      "name": "insulin (human)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Anatabine)",
      "function": "Abundance",
      "id": "c77d4080804731f0ef07ad52ed2fbccdac5d02fb2620d8800d273e925feebcbf90b94a2399efeb42a91e65413550e0f713cd431329129e1cdd90329cae6b3ff6",
      "name": "Anatabine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Hexamethonium)",
      "function": "Abundance",
      "id": "aeba6775e2c4756ac0affe8755ef603567a68e53e27cec2521b99002858b798c03a2627ab30f441d8198e36ff9f5004200eb276cdf10e4d02ef0b5e1bae4b476",
      "name": "Hexamethonium",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Mecamylamine)",
      "function": "Abundance",
      "id": "f81a5cca79277a3483157d6067c10b7916d6c4e183c85db0a42f5f427ebe2280a46a47f3899a13dfa89025b0f2b6dd3a0b02b3240d27c1c06be3d4a662516041",
      "name": "Mecamylamine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:adrenaline)",
      "function": "Abundance",
      "id": "bcab81cfe7bd509bdde904d67700eb80bb81fdf2e41bc0ba71061d5ee5f1cf657b917d0e8ec104f9e788feaefe992904a4b7002fc52ca7c52840bfeb6858ca6a",
      "name": "adrenaline",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:bupropion)",
      "function": "Abundance",
      "id": "6325adf3aa47db50f864da3548a361dd6e0e82f49641ed3643c36f506ee361952d01fe6a56b41572f25dcc17165e77066c09b5dcb42081b94e8b9704e5a32e39",
      "name": "bupropion",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:dopamine)",
      "function": "Abundance",
      "id": "70f7314679db5bae3c2260b6feff9a6ef3407fb6a585f92a58c59fd066a2ec279c0091a72edba3465c4f2aa033afff7fded0b16c4a84f4bbcecd092a934ea66e",
      "name": "dopamine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:glucose)",
      "function": "Abundance",
      "id": "ad228f723834a0438254651fae75410bfa5cb8ee6d9baa98af0240115b1e5ec55edb5d001429c764d8785ec034b6b90edc76a4b83d14572cae3624feacf85491",
      "name": "glucose",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:lactam)",
      "function": "Abundance",
      "id": "9fa7880e3291155c49b1e613d4ddd3dd4cade99fa94f63516696334b074d63074692d6bc76a39fd15a10718f5af26eb32581a28e515369924c36f5e77af34671",
      "name": "lactam",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "function": "Abundance",
      "id": "81813864e07e0e955a0ccf7e9ec2430ce5cdbeae237c18991897f8314b29bdb2d0985dedfa71377ab67541fbcea0567e323d0cf47a5517efc83a67ac442abdb8",
      "name": "nicotine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:nornicotine)",
      "function": "Abundance",
      "id": "0570abe45b9480f23e8b417b7c33142de07c7b27c3a3c842e80d7ef4b04df0972db64b14ce17b05267753ffadfbc9ddcbdc0b8c3046c0647ada1d884f9cb4668",
      "name": "nornicotine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:varenicline)",
      "function": "Abundance",
      "id": "fed219893919839171faea135762f0569613737568e5ee2f418d4d35e15b2c2b2ff5a03fa842e7ff502861611d5d9c4e6140c30de785caa9448a00929f49a6a7",
      "name": "varenicline",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
      "function": "Abundance",
      "id": "d4dab92458f9d400badc16e77625019cbef8195f4688bc8ed6598134926071f1f27c02db30d04ac878e51689f758ec9de2b17accf3aadd53aee0a622a941df73",
      "name": "Cholinergic receptors nicotinic subunits",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "a(MESH:\"Adrenal Glands\")",
      "function": "Abundance",
      "id": "75c630e7ec4ba9271f39956eafe963dadd7e5e6bf313ec45790e333edec9c3a0d40ac0a8fc2e99e637b359178115dc321fdb93027dc5fdc93f120b3a0ead002a",
      "name": "Adrenal Glands",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Blood Glucose\")",
      "function": "Abundance",
      "id": "5f682ebfa0393ed9b02a0f249c5eb94279018bc6e49dbe03ef785d9d29ac5edd937a890f445dc7b398734f81ab69efef040d95978e255c817c8255d0835fca23",
      "name": "Blood Glucose",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Central Nervous System\")",
      "function": "Abundance",
      "id": "1fe0c06a1530f3b8af3f023bf0ce521de8876c8c1b0f155dcea151c3fdd6742554432e6dbb7aa73df3e5bb75d304f288726f4c7510fbbcb0854947b7e2a9763e",
      "name": "Central Nervous System",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Dihydro-beta-Erythroidine\")",
      "function": "Abundance",
      "id": "ffc5021fdc725a48a185594f5c5bb68b41bcf9e1fb3be46e117db0370bbf7a69a45535d89cc6313079c5fbf573b7a47b35c6c888b499ab029910de98fd0f4989",
      "name": "Dihydro-beta-Erythroidine",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Receptors, Nicotinic\")",
      "function": "Abundance",
      "id": "ab9ab8a42f27ea8b317e817b34a7ed7609808e3ccad71f0ce8685fa7b9e53fd847534ce7483452cc11f2166657f178e8e6804466c34019ef9674372b725b155d",
      "name": "Receptors, Nicotinic",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"Toxic Actions\")",
      "function": "Abundance",
      "id": "d0a77d591b79dc5af5bab6bc54a49ce4867bb868f3c9347334883a9f831c648df14b300bef4cc0ccb7c3b10c81713d29f61a1bd720a71a4117679f3c9047ed90",
      "name": "Toxic Actions",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"alpha7 Nicotinic Acetylcholine Receptor\")",
      "function": "Abundance",
      "id": "24bfa0a4dedd705b999b510936aa1c989978fdeec807bf3046bd5178bd8e69ebbf2b1d2d2cd30ce5df8058656f59f497172cea193c9743a405bfb38be1aac50b",
      "name": "alpha7 Nicotinic Acetylcholine Receptor",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha3beta2\")",
      "function": "Abundance",
      "id": "bd643f5d99f7dc8b195fb484652ab4cdccf7e10e02ab4ee174b14b4fdb784066cf8c9d05f822422033f517d5bdc122d0bb5c59bc42d3d58379b8dbc4116b2b42",
      "name": "nicotinic receptor alpha3beta2",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha3beta4\")",
      "function": "Abundance",
      "id": "8475d37c04908bcfd277c15cb74825b455208745ea65a68a751fcf014d9d780f48004eeef5f6f5dad7f5f582c63d319304861af442eb2bdc4e078c4ff82b9755",
      "name": "nicotinic receptor alpha3beta4",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
      "function": "Abundance",
      "id": "578ab3081ab77f45ce59f4ab8967989183deed6d97d3ed106191c60681c2892922c60a63860a46e761cb87bb165c89a473430a438a17aa0a5d468b2f15f9d759",
      "name": "nicotinic receptor alpha4beta2",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Liver)",
      "function": "Abundance",
      "id": "05fa48b70f2e7a3be808b3f1388bcdf3e82b0d63da83243701905b82877dfc95736b78baff0740622aecae114958d429d0890fdc9e51b8ceecbddb035078f162",
      "name": "Liver",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Lung)",
      "function": "Abundance",
      "id": "2b51121a06c96faf8cb2423dc442bd4b3f8ccdaf8b25a92fe29e3accce42cea00ee13612dfa11e9df4d1a2bfc9c1373048f281eb26652ee2538ff7059693c185",
      "name": "Lung",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Tobacco)",
      "function": "Abundance",
      "id": "ce4d6fd11c1049ba443666246dd81ac4eca794295f7336e721f88621ec8b3af39b8d8df2bd64d1e3de49766a1737a141e07b2341e24ecbf6f5882af98657c654",
      "name": "Tobacco",
      "namespace": "MESH"
    },
    {
      "bel": "a(PUBCHEM:4032)",
      "function": "Abundance",
      "id": "d405e887cf83857f0ca6ba87a43aae95b1d9cc70f6ccab8bf4f13c93d93afb34b9a2c7160cbb7ea18b0e4e020dbf8df17276dba660c051920b8ca96d178390d7",
      "name": "4032",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:5288811)",
      "function": "Abundance",
      "id": "e7b320723ad1cf04389d8bfd5310cca17844b7ada93adaf4b44393ca7e3bb453de20e4551c7d00ada3096770f9434ea5a3b9e6ffba13103a6df5c0b91d40338f",
      "name": "5288811",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9306)",
      "function": "Abundance",
      "id": "00a843ac53042a269d9eaca6258758b75fe842822d7f44c30ee90c7b38e7a389465a0f4573e87e100561901e54cec243603d797024ef47e59f2b01bb4e80ad86",
      "name": "9306",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "function": "BiologicalProcess",
      "id": "9ddd1e2f8de9532f4c9e276a14aa2dbb15c257bbe5ac1b1c60dc9d758691015a32029e530fa94ebda65285da5fa8a399da7451a7e873368708276e6ec361d1e0",
      "name": "cellular respiration",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"nicotine metabolic process\")",
      "function": "BiologicalProcess",
      "id": "65dd43987a91f2a80fb8c192468c0fb72936207bdc78276a343cb6722b1e2bd884b05c5e558542597f549c1c62e9c1f5af15a621d3017fd4758ca6bab8c7082d",
      "name": "nicotine metabolic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:cognition)",
      "function": "BiologicalProcess",
      "id": "8d73f2caa1c473289d5f37cbdd4ad391a120cdbdf2356b373070c2a7b2bc0c785eaa620782fa2dd947c666100f0a169e81f35864f359cadf3e1550962fcc4127",
      "name": "cognition",
      "namespace": "GO"
    },
    {
      "bel": "bp(MESH:\"Heart Rate\")",
      "function": "BiologicalProcess",
      "id": "a9db0d03c176030975fcb0f87e6a8f242bd1abf328344e0117fbe69973c3825a4c57b6c00e4bae20ad8321cde6aa9c2e9eb837688bb1f65ef14ab298e39c1b36",
      "name": "Heart Rate",
      "namespace": "MESH"
    },
    {
      "bel": "complex(a(CHEBI:\"(-)-lobeline\"), a(MESH:\"nicotinic receptor alpha4beta2\"))",
      "function": "Complex",
      "id": "1ed2991f08768c38b7b16854b7853615d85fae1f11ba305bf096bdf2f82a739aee622251c707f16e86eb139b7a02a971d2526f02a47740ade82e42c5b957ba0f",
      "members": [
        {
          "bel": "a(CHEBI:\"(-)-lobeline\")",
          "function": "Abundance",
          "id": "62fc046ad070aff5fa50c81216a5aa24788d0d78742f84aeb0c986a551b36d28306234d309a861a0d68331e5b9fff631b9736bcedf4d2579c4c1262aa655e1f3",
          "name": "(-)-lobeline",
          "namespace": "CHEBI"
        },
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "function": "Abundance",
          "id": "578ab3081ab77f45ce59f4ab8967989183deed6d97d3ed106191c60681c2892922c60a63860a46e761cb87bb165c89a473430a438a17aa0a5d468b2f15f9d759",
          "name": "nicotinic receptor alpha4beta2",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\"))",
      "function": "Complex",
      "id": "e2fff624d37a23824988e6513db25e15b50e99130c39a29fbcfb0b8281d35e74f0ef7cf2bc595459b42b1fa54568a2749fc95bf62433481f3a0202c35d0b3fc6",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "function": "Abundance",
          "id": "81813864e07e0e955a0ccf7e9ec2430ce5cdbeae237c18991897f8314b29bdb2d0985dedfa71377ab67541fbcea0567e323d0cf47a5517efc83a67ac442abdb8",
          "name": "nicotine",
          "namespace": "CHEBI"
        },
        {
          "bel": "a(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
          "function": "Abundance",
          "id": "d4dab92458f9d400badc16e77625019cbef8195f4688bc8ed6598134926071f1f27c02db30d04ac878e51689f758ec9de2b17accf3aadd53aee0a622a941df73",
          "name": "Cholinergic receptors nicotinic subunits",
          "namespace": "HGNCGENEFAMILY"
        }
      ]
    },
    {
      "bel": "complex(a(CHEBI:nicotine), a(MESH:\"nicotinic receptor alpha4beta2\"))",
      "function": "Complex",
      "id": "663b1a43f2413a5d5b6ad7277c8ca80d3addd9a9c7cef896576f63b54b56f0e51781f47b42d8164d3db397e350b0fcd247e5f53dcec72be98c2ebfaf219cf638",
      "members": [
        {
          "bel": "a(CHEBI:nicotine)",
          "function": "Abundance",
          "id": "81813864e07e0e955a0ccf7e9ec2430ce5cdbeae237c18991897f8314b29bdb2d0985dedfa71377ab67541fbcea0567e323d0cf47a5517efc83a67ac442abdb8",
          "name": "nicotine",
          "namespace": "CHEBI"
        },
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "function": "Abundance",
          "id": "578ab3081ab77f45ce59f4ab8967989183deed6d97d3ed106191c60681c2892922c60a63860a46e761cb87bb165c89a473430a438a17aa0a5d468b2f15f9d759",
          "name": "nicotinic receptor alpha4beta2",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:\"Dihydro-beta-Erythroidine\"), a(MESH:\"nicotinic receptor alpha4beta2\"))",
      "function": "Complex",
      "id": "02d1139bece4de6d6304493c35a6815beb346ecab57df60d83861595b3b0994d4d358407e3d2b9f7b33d4958021644a54cc9ad34621392c37bc64083c84218f7",
      "members": [
        {
          "bel": "a(MESH:\"Dihydro-beta-Erythroidine\")",
          "function": "Abundance",
          "id": "ffc5021fdc725a48a185594f5c5bb68b41bcf9e1fb3be46e117db0370bbf7a69a45535d89cc6313079c5fbf573b7a47b35c6c888b499ab029910de98fd0f4989",
          "name": "Dihydro-beta-Erythroidine",
          "namespace": "MESH"
        },
        {
          "bel": "a(MESH:\"nicotinic receptor alpha4beta2\")",
          "function": "Abundance",
          "id": "578ab3081ab77f45ce59f4ab8967989183deed6d97d3ed106191c60681c2892922c60a63860a46e761cb87bb165c89a473430a438a17aa0a5d468b2f15f9d759",
          "name": "nicotinic receptor alpha4beta2",
          "namespace": "MESH"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:\"Dihydro-beta-Erythroidine\"), p(HGNC:CHRNB2))",
      "function": "Complex",
      "id": "49b0e7626417e95a311e4d0bb2ebdbd16647e47123d84dbc90d7c78f2a6034ce5b80835ac9e8d49ecb1b8843782290e3c66d5b36124dc7a4acef45167fb4463c",
      "members": [
        {
          "bel": "a(MESH:\"Dihydro-beta-Erythroidine\")",
          "function": "Abundance",
          "id": "ffc5021fdc725a48a185594f5c5bb68b41bcf9e1fb3be46e117db0370bbf7a69a45535d89cc6313079c5fbf573b7a47b35c6c888b499ab029910de98fd0f4989",
          "name": "Dihydro-beta-Erythroidine",
          "namespace": "MESH"
        },
        {
          "bel": "p(HGNC:CHRNB2)",
          "function": "Protein",
          "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
          "name": "CHRNB2",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(GO:\"I-kappaB/NF-kappaB complex\"))",
      "function": "Complex",
      "id": "9a8145ba5030069602b81da432380d41fbb8191cd657f89f26238e7c09be8641243edfd3f00f3327b1c7e54f00cf266cab17380de9562c561e9fc2f4be08bad9",
      "members": [
        {
          "bel": "p(GO:\"I-kappaB/NF-kappaB complex\")",
          "function": "Protein",
          "id": "80fd993357881424336f376a67db78e6dd9e6e042d0773d3920dfa1f189b24f63561530d6ad7694d4e3b36985a214c7ad22eb05625632d129c6c16b134f1c4fd",
          "name": "I-kappaB/NF-kappaB complex",
          "namespace": "GO"
        }
      ]
    },
    {
      "bel": "p(GO:\"I-kappaB/NF-kappaB complex\")",
      "function": "Protein",
      "id": "80fd993357881424336f376a67db78e6dd9e6e042d0773d3920dfa1f189b24f63561530d6ad7694d4e3b36985a214c7ad22eb05625632d129c6c16b134f1c4fd",
      "name": "I-kappaB/NF-kappaB complex",
      "namespace": "GO"
    },
    {
      "bel": "p(HGNC:CHRNB2)",
      "function": "Protein",
      "id": "fe8a0d337c8dfad7d9bbfcd38db3a76bbbfa276ae7af2e39600a1b845049505e52dd605173e1b8a8b67178c31bb8cde3f2669676e398c994800c15170b63033e",
      "name": "CHRNB2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Cholinergic receptors nicotinic subunits\")",
      "function": "Protein",
      "id": "d55bebfe65f49c8e66d1ed0b491af0f01aba4b030a649599e59150e53ed4d3e4cd2199be8863b95c7033ab2185d8d7ea9203e5418faea9d7dcc86757b9bcf4dd",
      "name": "Cholinergic receptors nicotinic subunits",
      "namespace": "HGNCGENEFAMILY"
    },
    {
      "bel": "path(MESH:\"Behavior, Addictive\")",
      "function": "Pathology",
      "id": "43e66698b879a871a66e11ad5a6226b99bd6bb6336b009cf4b2207b4ff96a4ddc04900e2589974a679ce296a12dd2f705c220addd477024be5a16602f788298f",
      "name": "Behavior, Addictive",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Bipolar Disorder\")",
      "function": "Pathology",
      "id": "37fc418bee04cdf181b18dc8606526e06aad7197584cb3e8d3ef50cb09a6f0ea55186a71687c07c10136195cbb3b3988d4029075b97cbf42568cc314a977d55e",
      "name": "Bipolar Disorder",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Blood Pressure\")",
      "function": "Pathology",
      "id": "e4341d2c2581b9109f422dc66f66b53ac15b678d903c8b015ef314af0e10b5f6a0bbbdf52750d1922f11f10cee0788827059b9617d6fd12500be2cc9ef3f654a",
      "name": "Blood Pressure",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Irritable Mood\")",
      "function": "Pathology",
      "id": "dc32a53f051746432afab52fac575e8aa4e99d2cdd367c7191e349adc6121926797504d078531450781cc1fbc5b6d9e6adc02060cedb821fa7e01971e764cb0b",
      "name": "Irritable Mood",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Motor Activity\")",
      "function": "Pathology",
      "id": "02fa1b20782328b40c24bcc0cff0b4ded4dba3b1e6bfd22a69d94400d2b97e0592b0c361b908443ab4ae3eab4b2f2df00df6e6630502fecb3d4f5740867e549b",
      "name": "Motor Activity",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Sleep Wake Disorders\")",
      "function": "Pathology",
      "id": "d375870a2858997d71c552e97fe201c51479ce5ea27ce24e1a819222bbd176e48ce09297bfc51b77a987ed5126926ca67b0817b64707ceb515b366fdc313c372",
      "name": "Sleep Wake Disorders",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Smoking Cessation\")",
      "function": "Pathology",
      "id": "297d269f2523b8bcac7b8d19fbac4cebe5e1f5feb69d02977efab3ce3a084e2412f41b77e3272973e1383f13343a7007e7b709b9c84e40bad5b206eb328bbf8f",
      "name": "Smoking Cessation",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Stress, Psychological\")",
      "function": "Pathology",
      "id": "a9409d3c9ae0cb6b62f28cb71a3a42e57dfd900a25116a57e9c5e069efaa1fd1cf552ea05ba2290b4144b682116b63f0fdc45bdee961115c5375c72b6942a086",
      "name": "Stress, Psychological",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Anger)",
      "function": "Pathology",
      "id": "306f41de2cd319533080b982f3106664d5c8ef649fed111bb76ae9f2e75e0915a1b30e6c9b4350548cb3e7172e98f2c8033901e7ef93c3f53181330084522134",
      "name": "Anger",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Anxiety)",
      "function": "Pathology",
      "id": "28f6f3390e4ae722f1c1298abe2059a3e03a8a2de93e506a747733d9e980ed28bb2feb1074ec430fda167d3f38e3c1d930e10c16e5e04f371938ce866caba0dc",
      "name": "Anxiety",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Appetite)",
      "function": "Pathology",
      "id": "108e61e1d2b0d1c9e5849f5f06f7866db544c461e219cde88dbcade29d7ab6ccacb697e50192f9b3dcf98e2e654c98965b8660b9c28602b261e5e60545774dcd",
      "name": "Appetite",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Attention)",
      "function": "Pathology",
      "id": "67735e2aaf2e17459a41794138aa7720fd27fb15a51cb7f34b74132b92accef7585efb2a338de3ca85bd2a5ae6bc4f7aac672d1a06b2e19c5e45400ba7b94036",
      "name": "Attention",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Confusion)",
      "function": "Pathology",
      "id": "6123db3d8a89419fa5464a3a3d01981e76bec8de0e5311d7df944e38edd7bdf970ca9b2807b7a608d0bbeb00b051f6bfb83fc43af97ce161fd8f1bb570695948",
      "name": "Confusion",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Craving)",
      "function": "Pathology",
      "id": "8de85da862b6cc27d0f4643dc7055a69f5070dac04a1edd8c34a36f4fb6540c477df493ea80b8b8c09b19009b305c407c4b1870858140e24ec2f3aab31ba63de",
      "name": "Craving",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Death)",
      "function": "Pathology",
      "id": "7277084fc3a1b0e377445b9052c02ac77fa754286debbdf8cfb948a489cda1bbfabab27531dc1a81026f92c278772709598e2982fd523d37d8d9b888532f8d63",
      "name": "Death",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Depression)",
      "function": "Pathology",
      "id": "1db8d744eac9b5ac408852b1889bb0b09e0054ea091932f1aa44aeeab0ea1b3825912c55c72fb2d25d5848e77d62b1c6a1df2063a2f25ae03e5ca30085922799",
      "name": "Depression",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Hypertension)",
      "function": "Pathology",
      "id": "d7bbfbcdb198ef3b72728fdf0b7777e015941a545078e2440fcc0c379e5132750dc90a45a2f159ec4d9a2c01d1626f108a0d3a782fcc7b59b4c00a945291a4a2",
      "name": "Hypertension",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Motivation)",
      "function": "Pathology",
      "id": "b908782cf50b441eb51c8ccf1b2f196ab2863a0ff830d0ad96fb00317e52d7ff256a463f0c182118f3e428aa4356fd9ea165a9fc27abb6f297e981592fbc9653",
      "name": "Motivation",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Pleasure)",
      "function": "Pathology",
      "id": "18a7ccaa37b67bc80b8eb8a07b4f87d72c9f9f049fe07c67db952176954c177fe331d5a52f808ff2f01789e88136ae035fc16bd9db6ef59ff7d732fdeb2ddccf",
      "name": "Pleasure",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Seizures)",
      "function": "Pathology",
      "id": "17403f3a1bd2329fb96ee7038a6e67660981b8ba37ab884dd21b5b81559748b6ded25528bc6726df2061dcf5cb2e00220a4b16c9c4dd77ac011964d4fbc15e23",
      "name": "Seizures",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Smoking)",
      "function": "Pathology",
      "id": "dc2c947a021ee2387a730d9914e614055029fcc02fb0400f5dbb3ab67ccf36d58d72c193d007c57de1f2549281c28ad1783671823dda38baf89d73fd59773372",
      "name": "Smoking",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Tremor)",
      "function": "Pathology",
      "id": "44639e46e8e327e4acb0ae6dcf63288eff2367d02c9afeffaa96c40d4ca635afe783fb0554056fb18ec9ac7c8aa8eb22c774e36930105ac8accea11655e04e44",
      "name": "Tremor",
      "namespace": "MESH"
    }
  ]
}